MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
🚨
Price Alert:
The stock price jumped by 36.18% after the earning call.
Show more
Cash Flow Overview
Change in Cash
-$85,727K
Free Cash flow
-$66,282K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of investments
Proceeds from the issuance of co...
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchase of investments
Trade accounts receivable
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-47,315
-79,045
-71,904
-91,253
Stock-based compensation expense
11,733
11,269
11,817
11,900
Unrealized foreign exchange loss (gain)
-3
-434
373
-232
Amortization of intangible assets
5,716
5,716
6,204
5,769
Amortization of right of use asset
902
1,876
2,716
2,922
Depreciation and amortization of property and equipment
3,784
2,823
3,724
2,986
Deferred tax benefit
-1,373
-665
184
-2,405
Excess and obsolescence reserve
3,314
-506
3,702
1,391
Accretion of discounts and premiums on investments
1,413
1,120
1,342
1,711
Loss on asset disposals
-642
-28
0
-44
Gain on loan forgiveness
1,000
-
-
-
Prepaid expenses, other assets and long-term assets
-5,910
1,466
661
-2,776
Trade accounts receivable
20,361
-690
15,687
6,823
Inventory
177
4,931
4,001
3,182
Operating lease liabilities
-773
-2,027
-2,900
-2,410
Accounts payable
-11,818
15,888
-5,213
-4,393
Accrued expenses and other liabilities
-8,615
-21,038
21,169
5,499
Net cash used in operating activities
-60,841
-72,074
-52,565
-78,702
Maturities of investments
61,000
74,000
70,000
120,000
Purchase of investments
129,609
55,998
59,905
92,144
Cash paid for acquisition, including contingent consideration, net of cash acquired
-
-
-
0
Purchase of property and equipment
5,441
6,608
9,320
10,844
Net cash provided by (used in) investing activities
-74,050
11,394
775
17,012
Tax payments related to shares withheld for vested restricted stock units
1,166
4,179
445
466
Proceeds from the issuance of common stock under employee stock purchase plan
861
-
839
2
Proceeds from the issuance of common stock upon exercise of options
26
-
0
0
Proceeds from the issuance of common stock, net
49,567
98,514
55,778
88,520
Net cash provided by financing activities
49,288
94,335
56,172
88,056
Effect of foreign exchange rate changes
-124
-213
577
-680
Net increase (decrease) in cash, cash equivalents and restricted cash
-85,727
33,442
4,959
25,686
Cash, cash equivalents and restricted cash beginning of period
202,500
169,058
178,049
178,049
Cash, cash equivalents and restricted cash end of period
116,773
202,500
169,058
164,099
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of common stock,...
$49,567K
(279.39%↑ Y/Y)
Proceeds from the
issuance of common stock...
$861K
(28.70%↑ Y/Y)
Proceeds from the
issuance of common stock...
$26K
Net cash provided by
financing activities
$49,288K
(272.55%↑ Y/Y)
Canceled cashflow
$1,166K
Net increase
(decrease) in cash, cash...
-$85,727K
(-116.29%↓ Y/Y)
Canceled cashflow
$49,288K
Maturities of investments
$61,000K
(-32.22%↓ Y/Y)
Stock-based compensation
expense
$11,733K
(-21.48%↓ Y/Y)
Prepaid expenses, other
assets and long-term...
-$5,910K
(-185.81%↓ Y/Y)
Amortization of intangible
assets
$5,716K
(0.32%↑ Y/Y)
Depreciation and
amortization of property and...
$3,784K
(12.52%↑ Y/Y)
Excess and
obsolescence reserve
$3,314K
(-60.13%↓ Y/Y)
Amortization of right of use
asset
$902K
(-68.65%↓ Y/Y)
Loss on asset
disposals
-$642K
Unrealized foreign
exchange loss (gain)
-$3K
(-101.92%↓ Y/Y)
Tax payments
related to shares...
$1,166K
(131.35%↑ Y/Y)
Net cash provided by
(used in) investing...
-$74,050K
(-634.97%↓ Y/Y)
Net cash used in
operating activities
-$60,841K
(9.79%↑ Y/Y)
Canceled cashflow
$61,000K
Canceled cashflow
$32,004K
Effect of foreign
exchange rate changes
-$124K
(-116.78%↓ Y/Y)
Purchase of investments
$129,609K
(88.67%↑ Y/Y)
Net loss
-$47,315K
(57.63%↑ Y/Y)
Trade accounts
receivable
$20,361K
(285.10%↑ Y/Y)
Purchase of property and
equipment
$5,441K
(-27.07%↓ Y/Y)
Accounts payable
-$11,818K
(-1423.40%↓ Y/Y)
Accrued expenses and
other liabilities
-$8,615K
(-2965.84%↓ Y/Y)
Accretion of discounts and
premiums on investments
$1,413K
(-29.46%↓ Y/Y)
Deferred tax benefit
-$1,373K
(-169.06%↓ Y/Y)
Gain on loan
forgiveness
$1,000K
Operating lease
liabilities
-$773K
(68.79%↑ Y/Y)
Inventory
$177K
(102.55%↑ Y/Y)
Buy us a coffee
IOVA_BIG-svg
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVA_BIG-svg
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)